Last reviewed · How we verify

Tums — Competitive Intelligence Brief

Tums (calcium carbonate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antacid, Calcium supplement. Area: Cardiovascular.

marketed Antacid, Calcium supplement Gastric acid (direct neutralization) Cardiovascular Inorganic salt Live · refreshed every 30 min

Target snapshot

Tums (calcium carbonate) — Generic (multiple manufacturers).

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Tums TARGET calcium carbonate Generic (multiple manufacturers) marketed Antacid, Calcium supplement Gastric acid (direct neutralization) 1930-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antacid, Calcium supplement class)

  1. Generic (multiple manufacturers) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tums — Competitive Intelligence Brief. https://druglandscape.com/ci/calcium-carbonate. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing